LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. (LENZ) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 49 transactions totaling $62.4M, demonstrating a bearish sentiment with -$30.8M in net insider flow. The most recent transaction on Nov 17, 2025 involved a sale of 5,788 shares valued at $152.6K.
LENZ Insider Activity Summary
Who Is Buying LENZ Stock?
No significant insider buying has been recorded for LENZ in the recent period.
Who Is Selling LENZ Stock?
No significant insider selling has been recorded for LENZ in the recent period.
Is LENZ Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LENZ is bearish with an Insider Alignment Score of 25/100 and a net flow of -$30.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
LENZ Frequently Asked Questions
Understanding LENZ Insider Activity
Insider trading at LENZ Therapeutics, Inc. (LENZ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading LENZ stock, having executed 49 transactions in the past 90 days. The most active insider is Vantage II Gp-gp, Llc Versant (Executive), who has made 7 transactions totaling $16.4M.
Related Tools
Track LENZ Therapeutics, Inc. Insider Activity
Get notified when executives and directors at LENZ file new Form 4 transactions